Atomistry » Fluorine » PDB 2weg-2x2f » 2weg
Atomistry »
  Fluorine »
    PDB 2weg-2x2f »
      2weg »

Fluorine in PDB 2weg: Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

Enzymatic activity of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

All present enzymatic activity of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors:
4.2.1.1;

Protein crystallography data

The structure of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors, PDB code: 2weg was solved by A.D.Scott, C.Phillips, A.Alex, A.Bent, R.O'brien, L.Damian, L.H.Jones, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 26.64 / 1.10
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 42.432, 41.223, 72.038, 90.00, 104.26, 90.00
R / Rfree (%) 16.5 / 18.3

Other elements in 2weg:

The structure of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors also contains other interesting chemical elements:

Zinc (Zn) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors (pdb code 2weg). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors, PDB code: 2weg:

Fluorine binding site 1 out of 1 in 2weg

Go back to Fluorine Binding Sites List in 2weg
Fluorine binding site 1 out of 1 in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1263

b:7.0
occ:1.00
 F A:FBV1263 0.0 7.0 1.0
C5 A:FBV1263 1.4 7.4 1.0
C4 A:FBV1263 2.4 7.3 1.0
C6 A:FBV1263 2.4 7.0 1.0
N A:THR200 3.0 5.3 1.0
S A:FBV1263 3.0 4.9 1.0
N2 A:FBV1263 3.0 5.1 1.0
O1 A:FBV1263 3.0 5.3 1.0
N A:THR199 3.1 4.8 1.0
OG1 A:THR200 3.2 7.5 1.0
CG2 A:THR200 3.4 6.8 1.0
CB A:LEU198 3.5 5.9 1.0
CB A:THR200 3.6 6.3 1.0
C1 A:FBV1263 3.6 8.8 1.0
C3 A:FBV1263 3.6 7.7 1.0
CA A:THR200 3.7 6.1 1.0
C A:THR199 3.8 5.2 1.0
OG1 A:THR199 3.8 5.0 1.0
C A:LEU198 3.8 4.5 1.0
CA A:LEU198 3.8 5.4 1.0
O A:THR200 3.9 5.9 1.0
CA A:THR199 4.0 5.3 1.0
C2 A:FBV1263 4.1 8.9 1.0
C A:THR200 4.2 6.3 1.0
O2 A:FBV1263 4.3 5.2 1.0
CD2 A:LEU198 4.4 7.6 1.0
CG A:LEU198 4.4 6.0 1.0
CB A:THR199 4.5 5.5 1.0
CD1 A:LEU198 4.8 7.4 1.0
ZN A:ZN1262 4.8 4.5 1.0
O A:LEU198 4.8 5.6 1.0
O A:THR199 4.9 5.7 1.0
C3 A:GOL1264 4.9 9.6 1.0
C1 A:GOL1264 5.0 7.5 1.0

Reference:

A.D.Scott, C.Phillips, A.Alex, M.Flocco, A.Bent, A.Randall, R.O'brien, L.Damian, L.H.Jones. Thermodynamic Optimisation in Drug Discovery: A Case Study Using Carbonic Anhydrase Inhibitors. Chemmedchem V. 4 1985 2009.
ISSN: ISSN 1860-7179
PubMed: 19882701
DOI: 10.1002/CMDC.200900386
Page generated: Wed Jul 31 16:25:07 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy